E-mail us: service@prospectnews.com Or call: 212 374 2800
Bank Loans - CLOs - Convertibles - Distressed Debt - Emerging Markets
Green Finance - High Yield - Investment Grade - Liability Management
Preferreds - Private Placements - Structured Products
 
Published on 9/11/2009 in the Prospect News PIPE Daily.

New Issue: Dara BioSciences arranges $2.5 million direct offering of equity units

By Devika Patel

Knoxville, Tenn., Sept. 11 - Dara BioSciences, Inc. said it will conduct a $2.5 million registered direct offering of units.

The company will sell 6,578,947 units of one common share and a warrant for 0.75 of a share at $0.38 per unit. Each whole warrant is exercisable at $0.616 for five years.

Capital Solutions, Inc. is the agent.

Settlement is expected Sept. 14.

Based in Raleigh, N.C., Dara is a pharmaceutical company that acquires therapeutic molecules and medical technologies.

Issuer:Dara BioSciences, Inc.
Issue:Units of one common share and one warrant for 0.75 of a share
Amount:$2.5 million
Units:6,578,947
Price:$0.38
Warrants:One warrant for 0.75 of a share per unit
Warrant expiration:Five years
Warrant strike price:$0.616
Agent:Capital Solutions, Inc.
Pricing date:Sept. 11
Settlement date:Sept. 14
Stock symbol:Nasdaq: DARA
Stock price:$0.56 at close Sept. 10
Market capitalization:$13.9 million

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.